Market Place
Sourcing Support
Veronica Gambillara Fonck Appointed Chair of MinervaX
14 Nov 2024 //
PR NEWSWIRE
MinervaX, Wacker Biotech Enter GBS Vax Pact
17 Sep 2024 //
CONTRACT PHARMA
MinervaX And Wacker Biotech Partner For Group B Streptococcus Vaccine
16 Sep 2024 //
PR NEWSWIRE
MinervaX Raises EUR 54M in Upsized Financing to Advance Group B Streptococcus
11 Oct 2023 //
PR NEWSWIRE
MinervaX raises €54M as it aims to move group B Streptococcus vaccine into PhIII
11 Oct 2023 //
ENDPTS
MinervaX Announces Completion of Enrolment in Phase I Clinical Vaccine Trial
27 Jun 2023 //
PR NEWSWIRE
MinervaX appoints Lidia Oostvogels as Chief Medical Officer
05 Jan 2023 //
PR NEWSWIRE
Danish seeking niche vaccine edge against Pfizer snags €72M for pivotal study
15 Dec 2022 //
ENDPTS
MinervaX announces 72M EUR financing to advance novel vaccine
15 Dec 2022 //
PRNEWSWIRE
MinervaX provides clinical and leadership update
07 Oct 2021 //
PRNEWSWIRE
Copyright © 2024 LePro PharmaCompass OPC Private Limited, All rights reserved.